Observational Safety Study of Clottafact® Fibrinogen Concentrate: Real-World Data in Mexico
Abstract
Background and objective: The use of fibrinogen concentrate to treat or prevent major bleeding with regard to potential adverse reactions has not been free of controversy. Our objective was to perform a post-authorization safety study to describe the use of Clottafact® (LFB Biomedicaments) fibrinogen concentrate in real-life medical practice in Mexico.